Impact of drug transporter studies on drug discovery and development

被引:360
|
作者
Mizuno, N
Niwa, T
Yotsumoto, Y
Sugiyama, Y
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan
[2] Mitsubishi Pharma Corp, Pharmacokinet Lab, Chiba, Japan
关键词
D O I
10.1124/pr.55.3.1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug transporters are expressed in many tissues such as the intestine, liver, kidney, and brain, and play key roles in drug absorption, distribution, and excretion. The information on the functional characteristics of drug transporters provides important information to allow improvements in drug delivery or drug design by targeting specific transporter proteins. In this article we summarize the significant role played by drug transporters in drug disposition, focusing particularly on their potential use during the drug discovery and development process. The use of transporter function offers the possibility of delivering a drug to the target organ, avoiding distribution to other organs (thereby reducing the chance of toxic side effects), controlling the elimination process, and/or improving oral bioavailability. It is useful to select a lead compound that may or may not interact with transporters, depending on whether such an interaction is desirable. The expression system of transporters is an efficient tool for screening the activity of individual transport processes. The changes in pharmacokinetics due to genetic polymorphisms and drug-drug interactions involving transporters can often have a direct and adverse effect on the therapeutic safety and efficacy of many important drugs. To obtain detailed information about these interindividual differences, the contribution made by transporters to drug absorption, distribution, and excretion needs to be taken into account throughout the drug discovery and development process.
引用
收藏
页码:425 / 461
页数:37
相关论文
共 50 条
  • [1] Drug transporter studies in drug discovery and development
    Mizuno, N
    Niwa, T
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 45P - 45P
  • [2] Pharmacogenetic and pharmacogenomic studies - Impact on drug discovery and drug development
    Alhenc-Gelas, FO
    Parmentier, L
    Bisagni, A
    [J]. THERAPIE, 2003, 58 (03): : 279 - 282
  • [3] EVALUATION OF DRUG TRANSPORTER REGULATION IN DRUG DISCOVERY AND DEVELOPMENT
    Ware, Joseph A.
    [J]. DRUG METABOLISM REVIEWS, 2014, 45 : 6 - 6
  • [4] Evaluation of Drug Transporter Interactions in Drug Discovery and Development
    Lai, Yurong
    Sampson, Kathleen E.
    Stevens, Jeffrey C.
    [J]. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2010, 13 (02) : 112 - 134
  • [5] Drug-transporter interaction testing in drug discovery and development
    Peter Krajcsi
    [J]. World Journal of Pharmacology, 2013, (01) : 35 - 46
  • [6] Technologies for transporter drug discovery
    Weinglass, Adam B.
    Garcia, Maria L.
    Kaczorowski, Gregory L.
    [J]. CHANNELS, 2008, 2 (05) : 312 - 321
  • [7] DRUG DISCOVERY Nirogy debuts to drug transporter proteins
    Cross, Ryan
    [J]. CHEMICAL & ENGINEERING NEWS, 2021, 99 (04) : 11 - 11
  • [8] In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development
    Brouwer, K. L. R.
    Keppler, D.
    Hoffmaster, K. A.
    Bow, D. A. J.
    Cheng, Y.
    Lai, Y.
    Palm, J. E.
    Stieger, B.
    Evers, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (01) : 95 - 112
  • [9] Application of transporter assays for drug discovery and development: an update of the literature
    Volpe, Donna A.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2024,
  • [10] Genome revolution: Impact on drug discovery and development
    Bailey, D
    Mackay, M
    [J]. DRUG DISCOVERY TODAY, 1996, 1 (03) : 126 - 126